Ayhan Savaşer

1.4k total citations
56 papers, 1.1k citations indexed

About

Ayhan Savaşer is a scholar working on Pharmaceutical Science, Analytical Chemistry and Pharmacology. According to data from OpenAlex, Ayhan Savaşer has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pharmaceutical Science, 13 papers in Analytical Chemistry and 11 papers in Pharmacology. Recurrent topics in Ayhan Savaşer's work include Drug Solubulity and Delivery Systems (17 papers), Advanced Drug Delivery Systems (17 papers) and Analytical Methods in Pharmaceuticals (13 papers). Ayhan Savaşer is often cited by papers focused on Drug Solubulity and Delivery Systems (17 papers), Advanced Drug Delivery Systems (17 papers) and Analytical Methods in Pharmaceuticals (13 papers). Ayhan Savaşer collaborates with scholars based in Türkiye, Serbia and North Macedonia. Ayhan Savaşer's co-authors include Yalçın Özkan, Çetin Taş, Síbel A. Özkan, Tamer Baykara, Cansel Köse Özkan, Özgür Eşi̇m, Umut Taşdemir, Nilufer Yüksel, Ayşegül Karataş and Aşkın Işimer and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and Journal of Electroanalytical Chemistry.

In The Last Decade

Ayhan Savaşer

56 papers receiving 1.0k citations

Peers

Ayhan Savaşer
Ayhan Savaşer
Citations per year, relative to Ayhan Savaşer Ayhan Savaşer (= 1×) peers Harinath N. More

Countries citing papers authored by Ayhan Savaşer

Since Specialization
Citations

This map shows the geographic impact of Ayhan Savaşer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayhan Savaşer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayhan Savaşer more than expected).

Fields of papers citing papers by Ayhan Savaşer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayhan Savaşer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayhan Savaşer. The network helps show where Ayhan Savaşer may publish in the future.

Co-authorship network of co-authors of Ayhan Savaşer

This figure shows the co-authorship network connecting the top 25 collaborators of Ayhan Savaşer. A scholar is included among the top collaborators of Ayhan Savaşer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayhan Savaşer. Ayhan Savaşer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yücel, Çiğdem, Özgür Eşi̇m, Nurgül K. Bakırhan, et al.. (2025). Metabolomic profiles altered by erlotinib encapsulated in poly(lactide-co-glycolide) nanoparticles in non-small cell lung cancer. Drug Development and Industrial Pharmacy. 51(5). 467–476. 1 indexed citations
2.
3.
Eşi̇m, Özgür, Merve Bacanlı, Cansel Köse Özkan, et al.. (2022). Evaluation of bacterial uptake, antibacterial efficacy against Escherichia coli , and cytotoxic effects of moxifloxacin-loaded solid lipid nanoparticles. Archives of Industrial Hygiene and Toxicology. 73(4). 260–269. 3 indexed citations
4.
Özkan, Cansel Köse, Özgür Eşi̇m, Ayhan Savaşer, & Yalçın Özkan. (2020). An Overview of Excipients Classification and Their Use in Pharmaceuticals. Current Pharmaceutical Analysis. 17(3). 360–374. 7 indexed citations
5.
Eşi̇m, Özgür, et al.. (2020). Effect simultaneous delivery with P-glycoprotein inhibitor and nanoparticle administration of doxorubicin on cellular uptake and in vitro anticancer activity. Saudi Pharmaceutical Journal. 28(4). 465–472. 17 indexed citations
6.
Kurbanoğlu, Sevinç, Özgür Eşi̇m, Cansel Köse Özkan, et al.. (2020). Stability Indicating Liquid Chromatographic Method for the Simultaneous Determination of Rosuvastatin and Ezetimibe from Pharmaceuticals and Biological Samples. Journal of the Turkish Chemical Society Section A Chemistry. 7(3). 865–874. 3 indexed citations
7.
Eşi̇m, Özgür, et al.. (2020). Development of Gemcitabine Loaded PLGA/Lecithin Nanoparticles for Non-Small Cell Lung Cancer Therapy. Current Drug Delivery. 17(7). 622–628. 5 indexed citations
8.
Eşi̇m, Özgür, Ayhan Savaşer, Leyla Karadurmuş, et al.. (2020). Current Status of Drug Delivery Approaches and Assay of Anti-Migraine Drugs. Current Drug Delivery. 18(2). 121–146. 3 indexed citations
9.
Eşi̇m, Özgür, et al.. (2020). Development, optimization and in vitro evaluation of oxaliplatin loaded nanoparticles in non-small cell lung cancer. DARU Journal of Pharmaceutical Sciences. 28(2). 673–684. 13 indexed citations
10.
Güçlü, Aylin Üsküdar, et al.. (2019). In vitro and in vivo evaluation of linezolid loaded electrospun PLGA and PLGA/PCL fiber mats for prophylaxis and treatment of MRSA induced prosthetic infections. International Journal of Pharmaceutics. 573. 118758–118758. 45 indexed citations
11.
Özkan, Cansel Köse, Eyüp Doğan, Özgür Eşi̇m, et al.. (2018). Evaluation of a novel oxiconazole nitrate formulation: The thermosensitive gel. Saudi Pharmaceutical Journal. 26(5). 665–672. 9 indexed citations
12.
Taş, Çetin, et al.. (2016). Delivery of Piroxicam With A Mucoadhesive Buccal Tablet: In Vitro, ExVivo and In Vivo Evaluation. 5(1). 3 indexed citations
13.
Eşi̇m, Özgür, et al.. (2016). Development of a Suitable Dissolution Method for the Combined Tablet Formulation of Atorvastatin and Ezetimibe by RP-LC Method. Current Drug Delivery. 13(3). 424–432. 6 indexed citations
14.
Özkan, Cansel Köse, Ayhan Savaşer, Çetin Taş, & Yalçın Özkan. (2010). The Development and In Vitro Evaluation of Sustained Release Tablet Formulations of Benzydamine Hydrochloride and its Determination. Combinatorial Chemistry & High Throughput Screening. 13(8). 683–689. 7 indexed citations
15.
Arsova‐Sarafinovska, Zorica, Ayşe Eken, Nadica Matevska-Geshkovska, et al.. (2009). Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer. Clinical Biochemistry. 42(12). 1228–1235. 115 indexed citations
16.
Doruk, Ali, et al.. (2006). Long-Term Methylphenidate Treatment Causes Increased Superoxide Dismutase Activity and Unchanged Lipid Peroxidation in Rat Brain. SHILAP Revista de lepidopterología. 16(2). 79–83. 2 indexed citations
17.
Taş, Çetin, et al.. (2006). Nasal absorption of metoclopramide from different Carbopol® 981 based formulations: In vitro, ex vivo and in vivo evaluation☆. European Journal of Pharmaceutics and Biopharmaceutics. 64(2). 246–254. 66 indexed citations
18.
Taş, Çetin, Yalçın Özkan, Ayhan Savaşer, & Tamer Baykara. (2004). In Vitro and Ex Vivo Permeation Studies of Chlorpheniramine Maleate Gels Prepared by Carbomer Derivatives. Drug Development and Industrial Pharmacy. 30(6). 637–647. 39 indexed citations
19.
Taş, Çetin, Yalçın Özkan, Ayhan Savaşer, & Tamer Baykara. (2003). In vitro release studies of chlorpheniramine maleate from gels prepared by different cellulose derivatives. Il Farmaco. 58(8). 605–611. 82 indexed citations
20.
Yüksel, Nilufer, Ayşegül Karataş, Yalçın Özkan, et al.. (2003). Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: in vitro and in vivo evaluation. European Journal of Pharmaceutics and Biopharmaceutics. 56(3). 453–459. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026